Lung Ablation Outcomes for Inoperable Stage IA Non–Small Cell Lung Cancer
Percutaneous cryoablation provides effective local control with a favorable safety profile in patients with medically inoperable Stage IA NSCLC particularly with tumor smaller than 2.0 cm. These results support further exploration of cryoablation as a primary treatment modality for this patient population.
Authors
- Robert D. Suh (ORCID: https://orcid.org/0000-0001-7872-9967)
- Dustin L Boyer
- Shreyas Naidu (ORCID: https://orcid.org/0000-0002-8747-3876)
- Sameer Rehman
- Nauman Jahangir
- Michael Schunk
- Syed Akbarullah
- Raja Shehayar Mehdi
Institutions
- University of California, Los Angeles (US)
- Centennial Hills Hospital (US)
- University of Florida (US)
- Society of Interventional Radiology (US)
- University Medical Center of Southern Nevada (US)
- Clinical Research Center of Nevada (US)
- Pulmonary Associates (US)
- nView Medical (United States) (US)
- Pulmonary and Critical Care Associates (US)
- Radiation Oncology Centers of Nevada (US)
- HealthPartners (US)
Publication Details
- Journal
- Journal of Vascular and Interventional Radiology
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1016/j.jvir.2025.107974
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00